N

Notch Therapeutics

83 employees

Notch develops immune cell therapy developing a next-generation pipeline that is compatible and focuses on initial cancer cells.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Developer Platform

Date founded

2018

Funding rounds raised

Total raised

$85M

from 6 investors over 6 rounds

N

Notch Therapeutics raised $85M on February 10, 2021

Investors: Lumira Ventures, Casdin Capital, LLC, Amplitude Ventures, CCRM and Samsara BioCapital

N

Notch Therapeutics raised undisclosed on January 1, 2018

Investors: Creative Destruction Lab

FAQ